JPRN-jRCT2080223308未知3 期
A phase III clinical study of HFT-290 in patients with cancer pain.
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with a diagnosis of cancer who are informed about their disease.
排除标准
- •- Patients with abnormalities at the target application site.
- •- Patients with serious cardiac, hepatic, or renal dysfunction, serious respiratory disease, or serious respiratory depression.
研究者
相似试验
已完成
3 期
Phase III study of HFT-290Cancer painJPRN-jRCT2080223661Hisamitsu Pharmaceutical Co., Inc.209
未知
3 期
Phase III clinical study in patients with chronic paiChronic painJPRN-jRCT2080221563Hisamitsu Pharmaceutical Co., Inc.
未知
3 期
ong-term phase III study in patients with chronic pain.Chronic painJPRN-jRCT2080221311Hisamitsu Pharmaceutical Co., Inc.
未知
2 期
Phase 2/3 clinical study of HP-3150 in patients with cancer pain.Cancer painJPRN-jRCT2080222905Hisamitsu Pharmaceutical Co., Inc
未知
2 期
Phase II clinical study of HP-3150 in patients with low back pain.ow back painJPRN-jRCT2080222960Hisamitsu Pharmaceutical Co., Inc